Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-22-029810

Options or other derivatives

  • Director acquired 0 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Pershing Edward · Director

Table II: Derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2022-09-23 Grant or award : show line 1 in the form 8% Unsecured Convertible Promissory Note due 2023 +0 $75,000.00 $0 D
2022-09-30 Grant or award : show line 2 in the form 8% Unsecured Convertible Promissory Note due 2023 +0 $110,000.00 $0 D
2022-10-14 Grant or award : show line 3 in the form 8% Unsecured Convertible Promissory Note due 2023 +0 $50,000.00 $0 D
2022-10-27 Grant or award : show line 4 in the form 8% Unsecured Convertible Promissory Note due 2023 +0 $7,500.00 $0 D
Loading xslF345X03/ownership.xml…